Arcutis Biotherapeutics starts eczema drug study
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Tri-county biotech firms tackle COVID-19 pandemic
Life sciences companies in the Tri-Counties are stepping up with treatments for COVID-19, led by leaders in inhalable drug technologies. Westlake Village-based MannKind said it expects $4.9 million in forgivable loan relief as part of the CARES Act, passed in March, as it explores four potential anti-infective and antiviral therapies. Separately, aerosolized drug delivery company Read More →
Read More →Amgen collaborating with Adaptive to create COVID-19 medicine
Thousand Oaks-based biotech giant Amgen announced April 2 that it is collaborating with Adaptive Biotechnologies to discover and develop antibodies that can be used to prevent or treat COVID-19. Amgen shares gained 4 percent to $205.88 as of 10:25 a.m and Adaptive’s stock was up 0.8 percent to $27.72. Year-to-date, Amgen’s stock is down 14 Read More →
Read More →Thousand Oaks buildings being redeveloped for biotech labs
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →T.O. industrial building sold for biotech lab redevelopment
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Atara burned cash but raised more during fourth quarter
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →